Involvement of the Fas/Fas ligand system in p53-mediated granulosa cell apoptosis during follicular development and atresia

Endocrinology

Volumn 140, Issue 5, 1999, Pages 2307-2317

  Kim, Jong Min ^a,b,e   Yoon, Yong Dal ^c   Tsang, Benjamin K ^a,b,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c Hanyang University   (South Korea)

^d UNIVERSITY OF OTTAWA   (Canada)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; GONADOTROPIN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GRANULOSA CELL; NONHUMAN; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 0033316264     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.5.6726     Document Type: Article

References (55)

1. Development of follicles in the mammalian ovary
2. ++)-dependent endonuclease activity in rat granulosa and luteal cells
3. Biochemical identification of apoptosis (programmed cell death) in granulosa cells: Evidence for a potential mechanism underlying follicular atresia
4. Involvement of apoptosis in ovarian follicular atresia and post ovulatory regression
5. Expression of members of the Bcl-2 gene family in the immature rat ovary equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased Bax and constitutive Bcl-2 and Bcl-x(long) messenger ribonucleic acid levels
6. Targeted overexpression of Bcl-2 in ovaries of transgenic mice decreases follicle apoptosis, increases litter size, and enhances tumoriogenesis
7. Intereukin-1β-converting enzyme-related proteases (IRPs) and mammalian cell death: Dissociation of IRP-induced oligonucleosomal endonuclease activity from morphological apoptosis in granulosa cells of the ovarian follicle
8. Caspase-3 in the rat ovary localization and possible role in follicular atresia and luteal regression
9. Regulation of granulosa cell inhibitor of apoptosis protein expression during ovarian follicular development and atresia
10. Identification of a deoxyribonuclease I-like endonuclease in rat granulosa and luteal cell nuclei
11. Expression of the p53 and Wilms' tumor suppressor genes in the rat ovary: Gonadotropin repression in vivo and immunohistochemical localization of nuclear p53 protein to apoptotic granulosa cells of atretic follicles
12. Involvment of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells
13. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia
14. Granulosa cell apoptosis induced at the penultimate stage of follicular development is aSsoCiated with increased levels of Fas and Fas ligand in the rat ovary
15. The polypeptide encoding the cDNA for human cell surface antigen Fas can mediate apoptosis
16. Molecular cloning and expression of the Fas ligand, a nobel member of the tumor necrosis factor family
17. Purification and characterization of the Fas-ligand that induces apoptosis
18. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor
19. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
20. Molecular cloning and expression of the Fas ligand, a noble member of the tumor necrosis factor family
21. Fas antigen-mediated apoptosis in human granulosa/luteal cells
22. Immunological evidence for the expression of the Fas antigen in the infant and adult human ovary during follicular regression and atresia
23. Transcriptional activation by p53 correlates with suppression of growth but not transformation
24. p53: Puzzle and paradigm
25. p53, the cellular gatekeeper for growth and division
26. Database of p53 gene somatic mutations in human tumors and cell lines
27. Human ovarian cancer of the surface epithelium
28. p53 is required for radiation induced apoptosis in mouse thymocytes
29. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal
30. Biochemical and histological validation of a model to study follicular atresia in rats
31. Heterogeneity in granulosa cells of developing rat follicles
32. Isolation of high molecular-weight DNA from mammalian cells
33. Microscale autoradiographic method for qualitative and quantitative analysis of apoptotic DNA fragmentation
34. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
35. A simple technique for the rescue of early region 1 mutation into infectious human adenovirus type 5
36. Swapping between Fas and granulocyte colony-stimulating factor receptor
37. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1)
38. Identification and localization of DNase I in the rat ovary
39. The p53 network
40. p53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes
41. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
42. Cyclin G is a transcriptional target of the p53 tumor suppressor protein
43. WAF1, a potential mediator of p53 tumor suppression
44. Induction of the growth inhibitor IGF-binding protein 3 by p53
45. A mammalian cell cycle checkpoit pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
46. mdm2 expression is induced by wild type p53 activity
47. Drug-induced apoptosis in heparoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
48. DNA damage induces phosphorylation of the amino terminus of p53
49. Functional activation of p53 via phosphorylation following DNA damage by UV but not γ radiation
50. A role for CD95 ligand in preventing graft rejection
51. Fas ligand-induced apoptosis as a mechanism of immune privilege
52. The effect of site of implantation on host reaction to ovarian homografts
53. Unravelling immune privilege